# TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
Canonical URL: https://biopharmsignal.com/news/TELA/tela-bio-announces-strategic-board-refreshment-with-four-highly-experienced-commerical-leaders-to-accelerate-growth-and-drive-path-to-profitability-the-company-also-reports-preliminary-first-quarter-2026-revenues
Ticker: TELA
Company: TELA Bio
Source: TELA Bio
Published: 2026-04-30 20:43 EST
Original Source URL: https://ir.telabio.com
## Summary

MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced a comprehensive board refreshment plan designed to support the Company’s next phase of

## Article Body
MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced a comprehensive board refreshment plan designed to support the Company’s next phase of
## Recent Company News
- 2026-05-12 20:05 EST — [TELA Bio Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TELA/tela-bio-reports-first-quarter-2026-financial-results) — Source: TELA Bio
- 2026-04-30 20:43 EST — [TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues](https://biopharmsignal.com/news/TELA/tela-bio-announces-strategic-board-refreshment-with-four-highly-experienced-commerical-leaders-to-accelerate-growth-and-drive-path-to-profitability-the-company-also-reports-preliminary-first-quarter-2026-revenues) — Source: TELA Bio
- 2026-04-21 20:05 EST — [TELA Bio to Announce First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TELA/tela-bio-to-announce-first-quarter-2026-financial-results) — Source: TELA Bio
- 2026-03-24 20:05 EST — [TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results](https://biopharmsignal.com/news/TELA/tela-bio-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: TELA Bio
- 2026-03-10 20:05 EST — [TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results](https://biopharmsignal.com/news/TELA/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results) — Source: TELA Bio
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)